ASAM is committed to improving access to high-quality, evidence-based addiction prevention and treatment through our national advocacy efforts.

National Advocacy

Working closely with lawmakers on Capitol Hill and leaders in the Administration, we advocate for policies that promote a stronger addiction treatment workforce, standardize the delivery of individualized addiction treatment, and ensure equitable access and coverage for comprehensive, high-quality addiction care.

advocacy-webpage-graphics-teach-it

TEACH addiction medicine by expanding and strengthening our workforce and dispelling stigma.

0. Advocacy Webpage Graphics Standardize It
STANDARDIZE the delivery of individualized addiction treatment so that more patients receive high-quality, evidence-based care.
0. Advocacy Webpage Graphics Cover It
COVER addiction medicine in a way that expands patient access to comprehensive, high-quality addiction care.
s1
Other Policy Areas include a wide range prevention efforts and research of substance-related problems.

MISAM Supports Changes to Pharmacy Controlled Substance Rules

by | Sep 13, 2021

On September 9th, the Michigan Society of Addiction Medicine (MISAM) submitted a comment letter to the Michigan Bureau of Professional Licensing in support of proposed changes to the pharmacy controlled substances rules of the Drug Treatment Prescriber Program. These revisions would eliminate burdensome requirements on the licensing of controlled substances and bring the state rules into closer alignment with federal standards.

In the letter, MISAM highlighted that the current rules of the Drug Treatment Prescriber Program require addiction specialist physicians (ASPs) to renew their controlled substances license every two-years. As part of the renewal process, applicants must pay a fee. This requirement needlessly builds upon the federal standard, placing disproportionate burdens on ASPs practicing in small, rural, and non-academic settings. Additionally, MISAM’s letter emphasized how waiving this requirement would increase patient access to medications for addiction treatment (MAT) by enabling ASPs in all areas of the state to build their treatment capacity.

 

Subscribe to the ASAM Advocate

Your source for timely, useful news briefings of top stories in addiction policy.